Mary‐Margaret Chren

11.9k total citations · 1 hit paper
142 papers, 8.0k citations indexed

About

Mary‐Margaret Chren is a scholar working on Dermatology, Epidemiology and Oncology. According to data from OpenAlex, Mary‐Margaret Chren has authored 142 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Dermatology, 54 papers in Epidemiology and 24 papers in Oncology. Recurrent topics in Mary‐Margaret Chren's work include Nonmelanoma Skin Cancer Studies (39 papers), Dermatology and Skin Diseases (35 papers) and Cutaneous Melanoma Detection and Management (19 papers). Mary‐Margaret Chren is often cited by papers focused on Nonmelanoma Skin Cancer Studies (39 papers), Dermatology and Skin Diseases (35 papers) and Cutaneous Melanoma Detection and Management (19 papers). Mary‐Margaret Chren collaborates with scholars based in United States, United Kingdom and Canada. Mary‐Margaret Chren's co-authors include Rebecca J. Lasek, C. Seth Landefeld, Eleni Linos, Sarah L. Chamlin, Linda Quinn, W. John Boscardin, Anju Sahay, Eliot N. Mostow, Stephen J. Zyzanski and Laura P. Sands and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Mary‐Margaret Chren

138 papers receiving 7.6k citations

Hit Papers

Skindex, a Quality-of-Life Measure for Patients with Skin... 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary‐Margaret Chren United States 51 4.2k 1.9k 1.1k 945 919 142 8.0k
Alan B. Fleischer United States 57 7.6k 1.8× 3.1k 1.7× 1.6k 1.5× 3.1k 3.2× 1.7k 1.9× 332 12.4k
Damiano Abeni Italy 60 4.3k 1.0× 2.3k 1.2× 1.5k 1.4× 2.3k 2.5× 610 0.7× 278 9.9k
Sam Salek United Kingdom 35 3.1k 0.7× 574 0.3× 364 0.3× 1.5k 1.6× 1.0k 1.1× 228 6.8k
Rajesh Balkrishnan United States 39 2.1k 0.5× 401 0.2× 525 0.5× 1.3k 1.4× 743 0.8× 195 6.9k
Marco DiBonaventura United States 44 1.3k 0.3× 954 0.5× 779 0.7× 299 0.3× 893 1.0× 198 7.3k
Adam Reich Poland 45 4.2k 1.0× 855 0.5× 477 0.4× 1.9k 2.0× 1.3k 1.5× 348 7.5k
April W. Armstrong United States 53 6.3k 1.5× 1.1k 0.6× 1.4k 1.3× 8.6k 9.1× 1.2k 1.3× 493 14.0k
Fabian Camacho United States 42 1.2k 0.3× 825 0.4× 893 0.8× 475 0.5× 316 0.3× 213 7.0k
Matthias Augustin Germany 62 9.2k 2.2× 1.9k 1.0× 1.2k 1.1× 7.9k 8.4× 2.4k 2.6× 821 17.5k
Deborah Symmons United Kingdom 87 1.6k 0.4× 2.4k 1.3× 1.3k 1.2× 6.9k 7.3× 245 0.3× 396 27.2k

Countries citing papers authored by Mary‐Margaret Chren

Since Specialization
Citations

This map shows the geographic impact of Mary‐Margaret Chren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary‐Margaret Chren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary‐Margaret Chren more than expected).

Fields of papers citing papers by Mary‐Margaret Chren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary‐Margaret Chren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary‐Margaret Chren. The network helps show where Mary‐Margaret Chren may publish in the future.

Co-authorship network of co-authors of Mary‐Margaret Chren

This figure shows the co-authorship network connecting the top 25 collaborators of Mary‐Margaret Chren. A scholar is included among the top collaborators of Mary‐Margaret Chren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary‐Margaret Chren. Mary‐Margaret Chren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halley, Meghan C., Mary‐Margaret Chren, Louise C. Walter, et al.. (2020). Development of a patient decision aid for the management of superficial basal cell carcinoma (BCC) in adults with a limited life expectancy. BMC Medical Informatics and Decision Making. 20(1). 81–81. 8 indexed citations
2.
Neugebauer, Romain, et al.. (2018). Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study. Journal of the American Academy of Dermatology. 80(4). 998–1005. 14 indexed citations
3.
Wehner, Mackenzie R., et al.. (2017). All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. 78(4). 663–672.e3. 27 indexed citations
4.
Stuart, Sarah, Chengshi Jin, Rupa Parvataneni, et al.. (2017). Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria. Journal of the American Academy of Dermatology. 76(6). 1131–1138.e1. 10 indexed citations
5.
Brindis, Claire D., et al.. (2017). Teens, Tweets, and Tanning Beds: Rethinking the Use of Social Media for Skin Cancer Prevention. American Journal of Preventive Medicine. 53(3). S86–S94. 62 indexed citations
6.
Wehner, Mackenzie R., Eleni Linos, Rupa Parvataneni, et al.. (2015). Timing of Subsequent New Tumors in Patients Who Present With Basal Cell Carcinoma or Cutaneous Squamous Cell Carcinoma. JAMA Dermatology. 151(4). 382–382. 60 indexed citations
7.
Linos, Eleni, Steven A. Schroeder, & Mary‐Margaret Chren. (2014). Potential Overdiagnosis of Basal Cell Carcinoma in Older Patients With Limited Life Expectancy. JAMA. 312(10). 997–997. 28 indexed citations
8.
Mathias, Susan D., Mary‐Margaret Chren, Hilary H. Colwell, et al.. (2013). Assessing Health-Related Quality of Life for Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome. JAMA Dermatology. 150(2). 169–169. 18 indexed citations
9.
Linos, Eleni, Rupa Parvataneni, Sarah Stuart, et al.. (2013). Treatment of Nonfatal Conditions at the End of Life. JAMA Internal Medicine. 173(11). 1006–1006. 66 indexed citations
10.
Chren, Mary‐Margaret, et al.. (2012). Tumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma. Journal of Investigative Dermatology. 133(5). 1188–1196. 125 indexed citations
11.
Chren, Mary‐Margaret, et al.. (2011). Recurrence After Treatment of Nonmelanoma Skin Cancer. Archives of Dermatology. 147(5). 540–540. 75 indexed citations
12.
Asgari, Maryam M., Jean Y. Tang, Ervin H. Epstein, et al.. (2009). Statin use and risk of basal cell carcinoma. Journal of the American Academy of Dermatology. 61(1). 66–72. 11 indexed citations
13.
Bertenthal, Daniel, et al.. (2007). Predictors of Skin-Related Quality of Life After Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma. Archives of Dermatology. 143(11). 1386–92. 53 indexed citations
14.
O’Hare, Ann M., Daniel Bertenthal, Anton N. Sidawy, et al.. (2006). Renal Insufficiency and Use of Revascularization among a National Cohort of Men with Advanced Lower Extremity Peripheral Arterial Disease. Clinical Journal of the American Society of Nephrology. 1(2). 297–304. 56 indexed citations
15.
Chren, Mary‐Margaret, Anju Sahay, Laura P. Sands, et al.. (2004). Variation in Care for Nonmelanoma Skin Cancer in a Private Practice and a Veterans Affairs Clinic. Medical Care. 42(10). 1019–1026. 24 indexed citations
16.
Sampogna, Francesca, Angelo Picardi, Mary‐Margaret Chren, et al.. (2004). Association Between Poorer Quality of Life and Psychiatric Morbidity in Patients With Different Dermatological Conditions. Psychosomatic Medicine. 66(4). 620–624. 109 indexed citations
17.
O’Hare, Ann M., Daniel Bertenthal, Michael G. Shlipak, Śaunak Sen, & Mary‐Margaret Chren. (2004). Impact of Renal Insufficiency on Mortality in Advanced Lower Extremity Peripheral Arterial Disease. Journal of the American Society of Nephrology. 16(2). 514–519. 101 indexed citations
18.
Shapiro, Michael B., Mary‐Margaret Chren, Ross M. Levy, et al.. (2004). Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. Journal of Cutaneous Pathology. 31(8). 523–530. 32 indexed citations
19.
Chren, Mary‐Margaret & C. Seth Landefeld. (1994). Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.. PubMed. 271(9). 684–9. 110 indexed citations
20.
Landefeld, C. Seth, Mary‐Margaret Chren, Rachel Geller, et al.. (1987). Major unexpected autopsy findings at university and community hospitals. Clinical research. 35(3). 352. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026